Parallax Volatility Advisers, L.P. Chemo Centryx, Inc. Put Options Transaction History

Parallax Volatility Advisers, L.P.

$53.5 Billion
Q3 2024

Put Options

3 transactions

Quarter	Operation	Price Per put	puts change	puts Held	SEC Form
Q4 2021 Feb 14, 2022	SELL	$18.38 - $40.5 $2.17 Million - $4.79 Million	-118,300 Reduced 99.92%	100 $4,000
Q3 2021 Nov 15, 2021	SELL	$13.18 - $19.83 $4.43 Million - $6.66 Million	-335,900 Reduced 73.94%	118,400 $2.03 Million
Q2 2021 Aug 16, 2021	BUY	$9.59 - $50.88 $4.36 Million - $23.1 Million	454,300 New	454,300 $6.08 Million

Others Institutions Holding CCXI

# of Institutions

6

Shares Held

66.3K

Call Options Held

0

Put Options Held

0

About ChemoCentryx, Inc.

Ticker CCXI
Exchange NASDAQ
Shares Outstandng 71,919,696
Market Cap $3.68M
Description
ChemoCentryx, Inc., a biopharmaceutical company, focuses on the development and commercialization of new medications for inflammatory disorders, autoimmune diseases, and cancer in the United States. It offers TAVNEOS (avacopan), an orally administered selective C5aR inhibitor for the treatment of adult patients with severe active anti-neutrophil...

More about CCXI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Parallax Volatility Advisers, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Parallax Volatility Advisers, L.P. with notifications on news.